home   |   contact us   |   sitemap     

 
   about Formula Pharmaceuticals  technology  pipeline NewsCareers  
   
   
             
   


Formula Pharmaceuticals, Inc. is a privately-held biopharmaceutical company developing a proprietary, next generation Chimeric Antigen Receptor (CAR) immunotherapy platform. Formula’s technology platform offers important opportunities for improvements to existing CAR approaches, with the objective to significantly increase patient access, clinical benefit potential, and cost-effectiveness of manufacturing.  Learn more >